Boekhoudt L, Roelofs T J M, de Jong J W, de Leeuw A E, Luijendijk M C M, Wolterink-Donselaar I G, van der Plasse G, Adan R A H
Brain Center Rudolf Magnus, Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.
Int J Obes (Lond). 2017 Jul;41(7):1131-1140. doi: 10.1038/ijo.2017.74. Epub 2017 Mar 21.
Dopamine (DA) signalling in the brain is necessary for feeding behaviour, and alterations in the DA system have been linked to obesity. However, the precise role of DA in the control of food intake remains debated. On the one hand, food reward and motivation are associated with enhanced DA activity. On the other hand, psychostimulant drugs that increase DA signalling suppress food intake. This poses the questions of how endogenous DA neuronal activity regulates feeding, and whether enhancing DA neuronal activity would either promote or reduce food intake.
Here, we used designer receptors exclusively activated by designer drugs (DREADD) technology to determine the effects of enhancing DA neuronal activity on feeding behaviour. We chemogenetically activated selective midbrain DA neuronal subpopulations and assessed the effects on feeding microstructure in rats.
Treatment with the psychostimulant drug amphetamine or the selective DA reuptake inhibitor GBR 12909 significantly suppressed food intake. Selective chemogenetic activation of DA neurons in the ventral tegmental area (VTA) was found to reduce meal size, but had less impact on total food intake. Targeting distinct VTA neuronal pathways revealed that specific activation of the mesolimbic pathway towards nucleus accumbens (NAc) resulted in smaller and shorter meals. In addition, the meal frequency was increased, rendering total food intake unaffected. The disrupted feeding patterns following activation of VTA DA neurons or VTA to NAc projection neurons were accompanied by locomotor hyperactivity. Activation of VTA neurons projecting towards prefrontal cortex or amygdala, or of DA neurons in the substantia nigra, did not affect feeding behaviour.
Chemogenetic activation of VTA DA neurons or VTA to NAc pathway disrupts feeding patterns. Increased activity of mesolimbic DA neurons appears to both promote and reduce food intake, by facilitating both the initiation and cessation of feeding behaviour.
大脑中的多巴胺(DA)信号传导对于进食行为是必需的,并且DA系统的改变与肥胖有关。然而,DA在控制食物摄入中的精确作用仍存在争议。一方面,食物奖励和动机与增强的DA活性相关。另一方面,增加DA信号传导的精神刺激药物会抑制食物摄入。这就提出了内源性DA神经元活动如何调节进食的问题,以及增强DA神经元活动是否会促进或减少食物摄入。
在这里,我们使用仅由设计药物激活的设计受体(DREADD)技术来确定增强DA神经元活动对进食行为的影响。我们通过化学遗传学方法激活选择性中脑DA神经元亚群,并评估对大鼠进食微观结构的影响。
用精神刺激药物苯丙胺或选择性DA再摄取抑制剂GBR 12909治疗可显著抑制食物摄入。发现腹侧被盖区(VTA)中DA神经元的选择性化学遗传学激活可减少餐量,但对总食物摄入量的影响较小。针对不同的VTA神经元通路的研究表明,向伏隔核(NAc)的中脑边缘通路的特异性激活导致餐量更小、进食时间更短。此外,进餐频率增加,使总食物摄入量不受影响。激活VTA DA神经元或VTA至NAc投射神经元后进食模式的紊乱伴随着运动活动亢进。激活投射至前额叶皮层或杏仁核的VTA神经元或黑质中的DA神经元,对进食行为没有影响。
VTA DA神经元或VTA至NAc通路的化学遗传学激活会扰乱进食模式。中脑边缘DA神经元活性的增加似乎通过促进进食行为的开始和停止来同时促进和减少食物摄入。